following a full submission
camellia sinensis (green tea) leaf extract (Catephen®) is accepted for restricted use within NHS Scotland.
Indication under review: Cutaneous treatment of external genital and perianal warts (condylomata acuminata) in immunocompetent patients from the age of 18 years.
SMC restriction: for use in patients not suitable for podophyllotoxin or who have not responded to treatment with podophyllotoxin.
Complete clearance of baseline and new warts was achieved in a significantly higher proportion of patients treated for up to 16 weeks with camellia sinensis (green tea) 10% ointment than vehicle ointment, in two phase III randomised double-blind studies.
Download detailed advice232KB (PDF)
- Medicine name:
- camellia sinensis (green tea leaf) (Catephen)
- SMC ID:
- for the cutaneous treatment of external genital and perianal warts (condylomata acuminata) in immunocompetent patients from the age of 18 years.
- Pharmaceutical company
- Kora Healthcare
- BNF chapter
- Submission type
- Date advice published:
- 10 April 2016